Obese Adults study: SC VK3019
Official title A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities
ClinicalTrials.gov ID: NCT07846033
What this study is testing
What is VK3019?
VK3019 is an investigational oral medication being studied for weight management in obese adults.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study will look at how safe and well the drug is, how it behaves in the body, and how it affects the body’s functions.
- Who it's for
- Adults who are overweight or obese and do not have other health conditions.
- What's involved
- Participants will receive either the drug or a placebo in a single dose, and will have blood tests and other safety checks.
- Time commitment
- The study lasts a few weeks, with a few clinic visits for dosing and monitoring.
- Phase 1: an early, usually small safety study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Must be capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent...
- Participants must be medically healthy, with no significant medical history, have no clinically significant abnormalities on physical examination at...
- Body mass index ≥ 27 kg/m2 and \< 40 kg/m2.
- Willing to comply with contraceptive requirements.
You likely can't join if
- Participants with any level of disease or organ system dysfunction as identified during physical examination, medical history or laboratory testing...
- Any surgical or medical condition (active or chronic) that may interfere with IP distribution, metabolism, excretion, or drug absorption.
- History or presence of clinically significant acute or unstable cerebrovascular (stroke), hepatic, renal, gastrointestinal, pulmonary, immunological...
- Current or prior diagnosis of diabetes mellitus (including type 1, type 2, except gestational diabetes).
- History of, or current, clinically significant liver disease, gallbladder disease (with the exception of Gilbert's Syndrome), as assessed by the...
- History of drug or alcohol abuse (ie, \>14 drinks/week for women or 21 drinks/week for men [1 drink = 150 mL of wine or 360 mL of beer or 45 mL of...
The study team makes the final eligibility decision.
Where it is enrolling
- Lake Forest, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Lake Forest, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.